Table 1. The characteristics, PET/CT and pathological results of these 18 enrolled breast cancer patients.
| No | Age | Cycle | ER | PR | HER2 | Ki67% | Stage | Maximum Diameter (cm) | SUVmax-FES | SUVmax-FDG | Ratio | Diagnosis |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 43 | 4 | 0 | 0 | 2 | 60 | IIB | 3.2 | 1.1 | 8.99 | 0.12 | R |
| 2 | 57 | 6 | 0 | 0 | 3 | 10 | IIB | 3.5 | 1.2 | 8.6 | 0.14 | R |
| 3 | 53 | 4 | 0 | 0 | 3 | 40 | IIIA | 6.9 | 1.3 | 7.2 | 0.18 | R |
| 4 | 28 | 4 | 2 | 1 | 2 | 50 | IIIA | 4.3 | 1.86 | 27.43 | 0.07 | R |
| 5 | 52 | 3 | 1 | 0 | 1 | 40 | IIIA | 5.1 | 2.06 | 13.88 | 0.15 | R |
| 6 | 62 | 4 | 0 | 0 | 3 | 30 | IIB | 4.6 | 1.4 | 6.06 | 0.23 | R |
| 7 | 49 | 4 | 3 | 3 | 2 | 40 | IIIA | 4.3 | 3.39 | 12.24 | 0.28 | R |
| 8 | 64 | 3 | 0 | 0 | 3 | 50 | IIIA | 7.5 | 1.01 | 15.8 | 0.06 | R |
| 9 | 49 | 3 | 3 | 3 | 2 | 50 | IIIA | 5.0 | 2.98 | 11.08 | 0.27 | R |
| 10 | 38 | 3 | 0 | 0 | 0 | 70 | IIA | 2.0 | 1.18 | 9.51 | 0.12 | R |
| 11 | 57 | 6 | 0 | 0 | 3 | 30 | IIIB | 12 | 2.35 | 16.63 | 0.14 | NR |
| 12 | 56 | 3 | 3 | 2 | 2 | 60 | IIIA | 4.8 | 5.1 | 11.96 | 0.43 | NR |
| 13 | 65 | 3 | 3 | 0 | 1 | 20 | IIB | 4.9 | 4.54 | 8.23 | 0.55 | NR |
| 14 | 65 | 4 | 2 | 2 | 2 | 50 | IIIA | 5.3 | 4.3 | 13.51 | 0.32 | NR |
| 15 | 48 | 3 | 3 | 2 | 2 | 20 | IIA | 2.7 | 2.05 | 5.15 | 0.4 | NR |
| 16 | 44 | 3 | 3 | 3 | 2 | 40 | IIIA | 3.8 | 5.91 | 7.3 | 0.81 | NR |
| 17 | 63 | 4 | 3 | 2 | 0 | 60 | IIA | 2.2 | 5.3 | 6.8 | 0.78 | NR |
| 18 | 64 | 4 | 3 | 3 | 1 | 20 | IIA | 2.1 | 5.8 | 6.3 | 0.92 | NR |
R=responder; NR=non-responder